Charles River Laboratories International, Inc. (NYSE: CRL) has acquired Celsis International Ltd.
Target Company Name |
Celsis International Ltd. |
---|---|
Target Country |
USA |
Description | Sale of Celsis International Ltd., a private equity portfolio company, to Charles River Laboratories International, Inc. (NYSE: CRL) for $212 million |
Global M&A Offices |
Brown Gibbons Lang & Company
(Global M&A USA)
|
Global M&A Advisory | Advisor to the seller |